Moreover, the synthetic molecule pirfenidone, recently approved for the treatment of idiopathic pulmonary fibrosis [173], was demonstrated to inhibit lung fibrosis by blocking both Hh [174,175] and TGF-β signaling [176,177]. This evidence concerns the gene TGFB1 and pulmonary fibrosis.